Spain Digital Pathology Market Size & Outlook, 2025-2033
The digital pathology market in Spain is expected to reach a projected revenue of US$ 53.3 million by 2033. A compound annual growth rate of 8.5% is expected of Spain digital pathology market from 2025 to 2033.
The Spain digital pathology market generated a revenue of USD 25.3 million in 2024 and is expected to reach USD 53.3 million by 2033.
The Spain market is expected to grow at a CAGR of 8.5% from 2025 to 2033.
In terms of segment, device was the largest revenue generating product in 2024.
Software is the most lucrative product segment registering the fastest growth during the forecast period.
Digital pathology market data book summary
Market revenue in 2024
USD 25.3 million
Market revenue in 2033
USD 53.3 million
Growth rate
8.5% (CAGR from 2025 to 2033)
Largest segment
Device
Fastest growing segment
Software
Historical data
2021 - 2023
Base year
2024
Forecast period
2025 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Software, Device, Storage Systems
Key market players worldwide
Danaher Corp, Hamamatsu Photonics KK, Koninklijke Philips NV, Olympus Corp, Roche Holding AG ADR, McCormick & Co Inc Registered Shs Non Vtg, Inspire Medical Systems Inc, PHC Holdings Corp, Huron Consulting Group Inc, CellaVision AB Bearer Shs, IBEX Ltd, Morphic Holding Inc, Nuvation Bio Inc Ordinary Shares - Class A
Other key industry trends
In terms of revenue, Spain accounted for 1.8% of the global digital pathology market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, Germany digital pathology market is projected to lead the regional market in terms of revenue in 2033.
UK is the fastest growing regional market in Europe and is projected to reach USD 149.6 million by 2033.
The digital pathology market in Spain is projected to exhibit constant growth rate throughout the forecast period. The growth can be attributed to strategic partnerships among key players and hospital & other healthcare providers across the country. In July 2016, Spanish Hospital Campus de la Salud and Philips Healthcare entered into an 8-year strategic partnership agreement to technologically upgrade and renew medical and laboratory equipment.
Strategies and guideline issued by the government organizations such as eHealth strategy issued by the European Commission for Spain are expected to create a positive impact on the market over the coming years. Product marketing & distribution approvals in the country is further anticipated to broaden the scope for growth of digital pathology market.
In June 2014, GE Healthcare received CE mark for Omnyx Integrated Digital Pathology and a high-volume slide scanner for primary diagnosis in the European Union. It is designed to connect pathologists as well as subspecialists and improve accuracy and provide greater diagnosis efficiency.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Digital Pathology Market Outlook will help companies and investors design strategic landscapes.
Device was the largest segment with a revenue share of 46.64% in 2024.
Horizon Databook has segmented the Spain digital pathology market based on software, device, storage systems covering the revenue growth of each sub-segment from 2021 to 2033.
The digital pathology market in Spain is projected to exhibit constant growth rate throughout the forecast period. The growth can be attributed to strategic partnerships among key players and hospital & other healthcare providers across the country. In July 2016, Spanish Hospital Campus de la Salud and Philips Healthcare entered into an 8-year strategic partnership agreement to technologically upgrade and renew medical and laboratory equipment.
Strategies and guideline issued by the government organizations such as eHealth strategy issued by the European Commission for Spain are expected to create a positive impact on the market over the coming years. Product marketing & distribution approvals in the country is further anticipated to broaden the scope for growth of digital pathology market.
In June 2014, GE Healthcare received CE mark for Omnyx Integrated Digital Pathology and a high-volume slide scanner for primary diagnosis in the European Union. It is designed to connect pathologists as well as subspecialists and improve accuracy and provide greater diagnosis efficiency.
Spain Digital Pathology Market Product Outlook (Revenue, USD Million , 2021-2033)
Software
Device
Storage Systems
Spain Digital Pathology Market Application Outlook (Revenue, USD Million , 2021-2033)
Drug Discovery & Development
Academic Research
Disease Diagnostics
Spain Digital Pathology Market End-Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Biotech & Pharmaceutical Companies
Diagnostic Labs
Academic & Research Institutes
Spain Digital Pathology Market Type Outlook (Revenue, USD Million , 2021-2033)
Human Pathology
Veterinary Pathology
Reasons to subscribe to Digital Pathology Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Digital Pathology Market Outlook databook
Our clientele includes a mix of Digital Pathology Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain Digital Pathology Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Spain Digital Pathology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.